Once daily Long‐acting beta2‐agonists/Inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic antagonists for people with chronic obstructive pulmonary disease

摘要

This is the protocol for a review and there is no abstract. The objectives are as follows:To compare a once‐daily combination of inhaled corticosteroid and long‐acting beta‐agonist inhalers (ICS/LABA) versus inhaled long‐acting muscarinic antagonists alone (LAMA) in people with chronic obstructive pulmonary disease (COPD).